Now is the Time for MS Screening Labs to Scale Up Projects

Calling all screening scientists! How will you fill the discovery funnel with high-quality hits? Scaling-up and accelerating mass spectrometry data analysis is a surefire way.

Register Free: https://www.biopharminternational.com/bp_w/screening-labs

Event Overview:

While mass spectrometry (MS) delivers better screening results in less time, the resulting tsunami of complex assays creates a data analysis bottleneck, which can take days up to weeks to overcome. These challenges are a thing of the past with Genedata Screener® for MS. Integrated with a wide range of MS instrumentation, Genedata Screener now includes ready-to-go analysis workflows for typical assay formats.

This webinar will demonstrate how the new MS application analyzes and reports on assay formats, such as multiplexed affinity selection MS (ASMS), multiple reaction monitoring (MRM), and various covalent binding assays. Scientists using MS as a technology to scale up and accelerate identification and validation now have an automated data analysis solution that matches MS throughput, which:

• Delivers high throughput screening and large-scale repeat analyses
• Provides plate-centric views enabling screening experts to analyze MS data
• Reduces analysis time through automation to unlock potential for higher throughput
• Offers systematic, unbiased QC

Key Learning Objectives:

• Overcome bottlenecks with high throughput analysis
• Simplify MS data analysis with templated, automated raw spectra processing workflows
• Easily identify molecules of interest with peak and cluster annotations

Featured Speaker:

Matthew Green, PhD
Mass Spectrometry Screening Lead
Genedata

At Genedata, Matthew Green PhD leads a diverse range of projects with many of the best pharmaceutical and biotechnology companies. With a background in biophysics and software development, he is an expert in automating analysis to increase insight and throughput to deliver digitization at an organizational level.

Matthew’s scientific and professional career has had an exciting trajectory through various complimentary cutting-edge fields, providing him uniquely well rounded insight into international biological research and the modern skills required to undertake it.
After a 'wet' PhD and Post-Docs in Molecular Biology, Matthew moved into biophysics, working at several of Europe's synchrotrons, and contributed to a successful spin-out venture now known as Akeso Biomedical. He later transitioned into bioinformatics and software development at the European Bioinformatics Institute, where he held several positions on international projects—most notably, construction of the Human Cell Atlas Data Coordination Platform in collaboration with developers at CZI and the Broad Institute.

Register Free: https://www.biopharminternational.com/bp_w/screening-labs